Skip to content

Role of homoeopathic medicines in cases of increased blood sugar levels

Effect Of Individualised Homoeopathic Medicines In Cases Of Prediabetes With Unavoidable Accessory Circumstances In Adult Population - A Prospective Single Arm Interventional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094872
Enrollment
65
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

Intervention1: Individualised Homoeopathic Medicines: Medicines will be prescribed in centesimal or LM scale potency Oral route of administration either in pills form globule size 30 or liquid form in

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with FBS between 100-125 mg/dl and/or OGTT between 140-199 mg/dl and/or HbA1c between 5.7%-6.4% Participants with presence of one or more unavoidable accessory circumstances like chronic stress, poor sleep hygeine, emotional conflicts, occupational stress, family related strain etc. Participants with no serious complications based on clinical evaluation Participants who give their valid consent to participate in the study

Exclusion criteria

Exclusion criteria: Participants who have diagnosed Type2 Diabetes Mellitus or any other systemic illness Participants who are on other medications for some other medical conditions or on antidiabetic medication of some other system Pregnant or lactating women Participants with a known psychiatric illness Participation in any other clinical trial during the study

Design outcomes

Primary

MeasureTime frame
To evaluate changes in glycemic levels (FBS, OGTT, HbA1c) before and after homoeopathic intervention and document and analyse the types of unavoidable accessory circumstances considered during remedy individualisationTimepoint: The study duration will be 16 months enrolment- 6 months follow up- 6 months data analysis- 2 months report writing- 2 months For statistical analysis FBS and OGTT will be recorded at baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks and HbA1c- at baseline, 12weeks and 24 weeks

Secondary

MeasureTime frame
To evaluate changes in the symptom burden using Diabetes Symptom Checklist- RevisedTimepoint: baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks

Countries

India

Contacts

Public ContactDr Rashid Akhtar

Bakson Homoeopathic Medical college and Hospital

rakhtar8@gmail.com9871894545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026